Ocular Therapeutix (OCUL) Non-Current Debt (2016 - 2025)

Historic Non-Current Debt for Ocular Therapeutix (OCUL) over the last 13 years, with Q4 2025 value amounting to $71.3 million.

  • Ocular Therapeutix's Non-Current Debt rose 413.25% to $71.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $71.3 million, marking a year-over-year increase of 413.25%. This contributed to the annual value of $71.3 million for FY2025, which is 413.25% up from last year.
  • According to the latest figures from Q4 2025, Ocular Therapeutix's Non-Current Debt is $71.3 million, which was up 413.25% from $70.6 million recorded in Q3 2025.
  • Ocular Therapeutix's Non-Current Debt's 5-year high stood at $71.3 million during Q4 2025, with a 5-year trough of $14.9 million in Q1 2021.
  • For the 5-year period, Ocular Therapeutix's Non-Current Debt averaged around $46.0 million, with its median value being $45.2 million (2023).
  • Per our database at Business Quant, Ocular Therapeutix's Non-Current Debt tumbled by 3515.03% in 2021 and then soared by 18808.31% in 2024.
  • Ocular Therapeutix's Non-Current Debt (Quarter) stood at $25.0 million in 2021, then rose by 1.03% to $25.3 million in 2022, then skyrocketed by 160.47% to $65.8 million in 2023, then grew by 4.13% to $68.5 million in 2024, then grew by 4.13% to $71.3 million in 2025.
  • Its Non-Current Debt was $71.3 million in Q4 2025, compared to $70.6 million in Q3 2025 and $69.9 million in Q2 2025.